{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:14:05Z","timestamp":1788225245746,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Eosinophilic pneumonia secondary to drug exposure is a recognized but infrequent complication associated with a variety of medications, including oncological therapies. Among immunomodulatory drugs, pulmonary toxicity has been described for thalidomide and lenalidomide but remains a rare complication.<\/jats:p>\n                  <jats:p>Pomalidomide is a third-generation immunomodulatory agent used in relapsed or refractory multiple myeloma. It has been authorized in Europe since 2013. To date, only a limited number of cases of pomalidomide-induced lung injury, and even fewer cases of eosinophilic pneumonia, have been documented in the literature.<\/jats:p>\n                  <jats:p>We present a case of eosinophilic pneumonia attributed to pomalidomide in a 67-year-old patient receiving daratumumab, pomalidomide, and dexamethasone for relapsed multiple myeloma. The diagnosis was supported by compatible respiratory symptoms and imaging, bronchoalveolar lavage eosinophilia, exclusion of alternative causes, lack of clinical improvement with empirical antibiotics, and rapid improvement after pomalidomide withdrawal and systemic corticosteroid therapy.<\/jats:p>\n                  <jats:p>Prompt recognition of this rare adverse event, discontinuation of pomalidomide, and corticosteroid therapy resulted in rapid clinical and radiological improvement, with sustained pulmonary function recovery at 12-month follow-up.<\/jats:p>","DOI":"10.1186\/s12890-026-04438-1","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:35:39Z","timestamp":1781951739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pomalidomide-induced acute eosinophilic pneumonia: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Mathieu","family":"Megevet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Freitas Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Vervier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Lovey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Soubeyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8021-0950","authenticated-orcid":false,"given":"Pierre-Olivier","family":"Bridevaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"4","key":"4438_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1182\/blood-2016-02-700872","volume":"128","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos MA, Palumbo A, Corradini P, et al. Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma. Blood. 2016;128(4):497\u2013503.","journal-title":"Blood"},{"key":"4438_CR2","unstructured":"European Medicines Agency. Imnovid: EPAR - product information. Date of first authorisation: 05 August 2013. Accessed. June 2026. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/imnovid"},{"issue":"34","key":"4438_CR3","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1200\/JCO.2016.69.3812","volume":"34","author":"MN Polizzotto","year":"2016","unstructured":"Polizzotto MN, Uldrick TS, Wyvill KM, et al. Pomalidomide for symptomatic Kaposi\u2019s sarcoma in people with and without HIV infection: a phase I\/II study. J Clin Oncol. 2016;34(34):4125\u201331. https:\/\/doi.org\/10.1200\/JCO.2016.69.3812.","journal-title":"J Clin Oncol"},{"issue":"10","key":"4438_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/jcm7100356","volume":"7","author":"S Skeoch","year":"2018","unstructured":"Skeoch S, Weatherley N, Swift AJ, et al. Drug-induced interstitial lung disease: a systematic review. J Clin Med. 2018;7(10):356. https:\/\/doi.org\/10.3390\/jcm7100356.","journal-title":"J Clin Med"},{"issue":"5","key":"4438_CR5","first-page":"438","volume":"47","author":"H Matsushima","year":"2009","unstructured":"Matsushima H, Oda T, Yamamoto M, et al. Case of thalidomide-induced interstitial pneumonia. Nihon Kokyuki Gakkai Zasshi. 2009;47(5):438\u201342.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"4438_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1757-1626-1-143","volume":"1","author":"L Tilluckdharry","year":"2008","unstructured":"Tilluckdharry L, Dean R, Farver C, et al. Thalidomide-related eosinophilic pneumonia: a case report and brief literature review. Cases J. 2008;1:143. https:\/\/doi.org\/10.1186\/1757-1626-1-143.","journal-title":"Cases J"},{"issue":"6","key":"4438_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.arbres.2016.10.011","volume":"53","author":"E Cabrera Cesar","year":"2017","unstructured":"Cabrera Cesar E, Fernandez Aguirre MC, Gonzalez Fernandez A. Lung toxicity after lenalidomide treatment in a patient with multiple myeloma. Arch Bronconeumol. 2017;53(6):355\u20136. https:\/\/doi.org\/10.1016\/j.arbres.2016.10.011.","journal-title":"Arch Bronconeumol"},{"issue":"127","key":"4438_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1183\/09059180.00001912","volume":"22","author":"K Amraoui","year":"2013","unstructured":"Amraoui K, Belhadj K, Maitre B, Janniere-Nartey C, Dupuis J. Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients. Eur Respir Rev. 2013;22(127):93\u20135. https:\/\/doi.org\/10.1183\/09059180.00001912.","journal-title":"Eur Respir Rev"},{"issue":"4","key":"4438_CR9","doi-asserted-by":"publisher","first-page":"e00233","DOI":"10.1002\/rcr2.233","volume":"5","author":"A Toma","year":"2017","unstructured":"Toma A, Rapoport AP, Burke A, Sachdeva A. Lenalidomide-induced eosinophilic pneumonia. Respirol Case Rep. 2017;5(4):e00233. https:\/\/doi.org\/10.1002\/rcr2.233.","journal-title":"Respirol Case Rep"},{"issue":"4","key":"4438_CR10","doi-asserted-by":"publisher","first-page":"e9688","DOI":"10.1097\/MD.0000000000009688","volume":"97","author":"C Bartal","year":"2018","unstructured":"Bartal C, Sagy I, Barski L. Drug-induced eosinophilic pneumonia: a review of 196 case reports. Med (Baltim). 2018;97(4):e9688. https:\/\/doi.org\/10.1097\/MD.0000000000009688.","journal-title":"Med (Baltim)"},{"issue":"9","key":"4438_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1164\/rccm.2112056","volume":"166","author":"F Philit","year":"2002","unstructured":"Philit F, Etienne-Mastroianni B, Parrot A, Guerin C, Robert D, Cordier JF. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med. 2002;166(9):1235\u20139. https:\/\/doi.org\/10.1164\/rccm.2112056.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4438_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1378\/chest.10-2082","volume":"140","author":"HL Geyer","year":"2011","unstructured":"Geyer HL, Viggiano RW, Lacy MQ, et al. Acute lung toxicity related to pomalidomide. Chest. 2011;140(2):529\u201333. https:\/\/doi.org\/10.1378\/chest.10-2082.","journal-title":"Chest"},{"key":"4438_CR13","doi-asserted-by":"publisher","unstructured":"Sasieta Tello HC, Bhaskar N, McKee S, Johnson LG. Diffuse alveolar hemorrhage related to pomalidomide. Am J Respir Crit Care Med. 2013;187:A5041. https:\/\/doi.org\/10.1164\/ajrccm-conference.2013.187.1_MeetingAbstracts.A5041","DOI":"10.1164\/ajrccm-conference.2013.187.1_MeetingAbstracts.A5041"},{"issue":"3","key":"4438_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/MAJ.0000000000000532","volume":"350","author":"D Modi","year":"2015","unstructured":"Modi D, Mamdani H, Vettese T. Pomalidomide-induced pulmonary toxicity in multiple myeloma. Am J Med Sci. 2015;350(3):241\u20132. https:\/\/doi.org\/10.1097\/MAJ.0000000000000532.","journal-title":"Am J Med Sci"},{"issue":"11","key":"4438_CR15","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.5588\/ijtld.18.0244","volume":"22","author":"S Gajic","year":"2018","unstructured":"Gajic S, Callahan EC, Brown JK, Elicker B, Ley B, Blanc PD. Pulmonary toxicity associated with pomalidomide. Int J Tuberc Lung Dis. 2018;22(11):1383\u20136. https:\/\/doi.org\/10.5588\/ijtld.18.0244.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"4438_CR16","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1097\/MJT.0000000000000870","volume":"28","author":"BL Icard","year":"2021","unstructured":"Icard BL, Singh V, Loschner AL. Pomalidomide-associated pulmonary toxicity. Am J Ther. 2021;28(1):e143\u20134. https:\/\/doi.org\/10.1097\/MJT.0000000000000870.","journal-title":"Am J Ther"},{"issue":"2","key":"4438_CR17","doi-asserted-by":"publisher","first-page":"e32473","DOI":"10.1097\/MD.0000000000032473","volume":"102","author":"A Vivien","year":"2023","unstructured":"Vivien A, Ancel J, Godet S, et al. Pomalidomide-induced lung injury: a case report. Med (Baltim). 2023;102(2):e32473. https:\/\/doi.org\/10.1097\/MD.0000000000032473.","journal-title":"Med (Baltim)"},{"key":"4438_CR18","doi-asserted-by":"publisher","unstructured":"Carter DJ, Ellaicy O, Distel CJ, Khan MMKS. A case of pomalidomide induced acute eosinophilic pneumonia. Am J Respir Crit Care Med. 2024;209:A3853. https:\/\/doi.org\/10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A3853","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A3853"},{"issue":"5","key":"4438_CR19","doi-asserted-by":"publisher","first-page":"e1001444","DOI":"10.1371\/journal.pmed.1001444","volume":"10","author":"EBM Spuesens","year":"2013","unstructured":"Spuesens EBM, Fraaij PLA, Visser EG, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444. https:\/\/doi.org\/10.1371\/journal.pmed.1001444.","journal-title":"PLoS Med"},{"issue":"2","key":"4438_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345. https:\/\/doi.org\/10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"4438_CR21","doi-asserted-by":"publisher","first-page":"e267801","DOI":"10.1136\/bcr-2025-267801","volume":"18","author":"N Momi","year":"2025","unstructured":"Momi N, Ramesh V, Vasudevan AK, Gunasekaran K. Acute interstitial pneumonitis associated with daratumumab treatment. BMJ Case Rep. 2025;18(9):e267801. https:\/\/doi.org\/10.1136\/bcr-2025-267801.","journal-title":"BMJ Case Rep"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04438-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:26:39Z","timestamp":1788222399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04438-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4438"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04438-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Under Swiss law, formal ethics committee approval is not required for publication of a single anonymized case report.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from the patient.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"388"}}